Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
1/2019 ceased to operate
Touch Brain
Touch Brain Overview
Touch Brain has developed novel formulations of existing drugs that result in unique activity for the treatment of large-market central nervous system diseases. Touch Brain's technology is based on proprietary formulations for intranasal administration and novel combinations of approved drugs. The intranasal route holds many advantages including increased bio-availability, elimination of first-pass metabolism, improvement of brain targeting, convenience, and patient compliance.